Thesis (M.A.)--Boston University

Orientador : Nubor Orlando Facure / Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas / Made available in DSpace on 2018-07-16T15:33:02Z (GMT). No. of bitstreams: 1 Quagliato_ElizabethMariaAparecidaBarasnevicius_D.pdf: 3313266 bytes, checksum: a949dd00e6284886ba5ed5ae723f952b (MD5) Previous issue date: 1987 / Resumo: No período de 1982 a 1986 selecionamos 96 pacientes com forma epiléptica da cisticercose encefálica, prove nientes do Ambulatório de Neuroiogia do Hospital das Clínicas da Faculdade de Ciências Médicas da UNICAMP. A cisticercose encefálica foi o diagnóstico etiológico qe 15% dos epilépticos da população estudada. o diagnóstico de cisticercose encefálica fundamentou-se nos resultados obtidos através do RX de crânio, TCC e LCR. Os pacientes foram classificados em quatro grupos, de acordo com o diagnóstico de: 1. Certeza - quando a apresençü do cisticerco foi confirmada no SNC através de cirurgia (seis casos). 2. Segurança - pacientes com imunologia específica positiva no LCR e cistos viáveis na TCC (12 casos) ou pacientes com cisticercose muscular e subcutânea confirmada por biópsia e TCC demonstrando formas císticas viáveis (dois casos). (Continua...) / Abstract: At the Epilepsy Outpatient unit of Unicamp School of Medicine Hospital, ninety six patients were diagnosed as having the .epileptic form of neurocysticercosis in the period of time between 1982 and 1986. In approximate1y 15.% of the patient popu1ation with epilepsy that we studied, the etiology of the seizures was neurocysticercosis. Diagnosis was made by means of Computed Tomography (CT), p1ain skull X-rays and cerebral spinal fluid (CSF) analysis. We used the following diagnostic cri teria: 1. Certainty - when cysticerci were demonstrated in central nervous system tissue through surgery (six patients). 2. Security - a) when antibodies against cysticerci were detected in CSF by means of complement fixation test or indirect hemagglutination and two or more cystic lesions were displayed by CT (12 patients). b) when cysticerci were obtained after biopsy of muscle or subcutaneous tissue and the CT showed two or more cystic lesions (two patients) / Doutorado / Doutor em Medicina

A cerebrospinal fluid (CSF) shunt system is used for treatment of hydrocephalus and abnormal intracranial pressure (ICP) conditions. Mostly a shunt system is placed under skin for creating a low resistance pathway between intracranial space and appropriate discharge sites within body by doing so excess CSF volume can exit the intracranial space. Displaced intracranial CSF volume normally results in lowered ICP. Thereby, a CSF shunt can manage ICP. In a healthy person, normal ICP is primarily maintained by CSF production and reabsorption rate as a natural tendency of body. If intracranial CSF volume starts increasing due to under reabsorption, this mostly results in raised ICP. Abnormal ICP can be treated by discharging excess CSF volume via use of a shunt system. Once a shunt system is placed subcutaneously, a patient is expected to live a normal life. However, shunt failure as well as flow regulatory problems are major issues with current passive shunt systems which leaves patients with serious consequences of under-/over CSF drainage condition. In this research, a shunt system is developed which is resistant to most shunt-related causes of under-/over CSF drainage. This has been made possible via use of an on-board medical monitoring (diagnostic) and active flow control mechanism. The developed shunt system, in this research, has full external ventricular drainage (EVD) capability. Further miniaturization will make it possible for an implantable shunt. / Includes bibliography. / Thesis (M.S.)--Florida Atlantic University, 2020. / FAU Electronic Theses and Dissertations Collection

No description available.

No description available.

No description available.

Diss. (sammanfattning) Stockholm : Karol. inst. / Härtill 7 uppsatser.

Inaug.-Diss.--Friedrich-Wilhelms-Universitat, Bonn. / Vita. Includes bibliographical references.

Inaug.-Diss.--Friedrich-Wilhelms-Universitat, Bonn. / Vita. Includes bibliographical references.

Thesis (M.S.)--Brigham Young University. Dept. of Electrical and Computer Engineering, 2006. / Includes bibliographical references (p. 79-81).